首页> 外文期刊>Human and Experimental Toxicology >Regulatory risk assessments: Is there a need to reduce uncertainty and enhance robustness?
【24h】

Regulatory risk assessments: Is there a need to reduce uncertainty and enhance robustness?

机译:监管风险评估:是否需要减少不确定性并增强稳健性?

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

A critical evaluation of several recent regulatory risk assessments has been undertaken. These relate to propyl paraben (as a food additive, cosmetic ingredient or pharmaceutical excipient), cobalt (in terms of a safety-based limit for pharmaceuticals) and the cancer Threshold of Toxicological Concern as applied to food contaminants and pharmaceutical impurities. In all cases, a number of concerns can be raised regarding the reliability of the current assessments, some examples being absence of data audits, use of single-dose and/or non-good laboratory practice studies to determine safety metrics, use of a biased data set and questionable methodology and lack of consistency with precedents and regulatory guidance. Drawing on these findings, a set of recommendations is provided to reduce uncertainty and improve the quality and robustness of future regulatory risk assessments.
机译:对最近最近的监管风险评估进行了关键评估。 这些涉及丙基帕拉塞(作为食品添加剂,化妆品成分或药物赋形剂),钴(根据药物的安全基础)和应用于食品污染物和药物杂质的毒理学关注的癌症阈值。 在所有情况下,可以提出许多问题,关于当前评估的可靠性,一些例子缺乏数据审核,使用单剂量和/或非良好实验室实践研究来确定安全指标,使用偏置 数据集和可疑的方法论和缺乏与先例和监管指导的一致性。 绘制这些调查结果,提供了一系列建议,以减少不确定性,提高未来监管风险评估的质量和稳健性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号